ReviewChinese medical journal2026
Advances in vascularized organoids.
Review in Chinese medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractThe development of organoid technology has led to notable advances in regenerative medicine, disease modeling, and drug screening. However, given the pivotal role of vascular systems in growth maintenance and nutrient delivery, the lack of functional vascular networks within organoids limits the scalability and physiological functionality of these organoids. Efforts to explore strategies for organoid vascularization, such as co-culture, transcription factor induction, microfluidic technology, and the application of biomaterial scaffolds, are underway. These methods have shown distinct advantages across different types of organoids, partially addressing vascularization challenges. However, issues such as limited vascular network integration and insufficient functional maturity remain unresolved. Future efforts should prioritize the development of multi-tiered vascular networks, the application of smart biomaterials, and the creation of personalized vascularized organoids. This review summarizes the advances in this field and explores the potential translation of vascularized organoids into clinical practice, offering recommendations for further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.